Jagiellonian University Repository

Impact of intra-aortic balloon pump on long-term mortality of unselected patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock

pcg.skipToMenu

Impact of intra-aortic balloon pump on long-term mortality of unselected patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock

Show full item record

dc.contributor.author Dziewierz, Artur [SAP20011458] pl
dc.contributor.author Siudak, Zbigniew [SAP20011644] pl
dc.contributor.author Rakowski, Tomasz [SAP20012839] pl
dc.contributor.author Kleczyński, Paweł [SAP20010977] pl
dc.contributor.author Zasada, Wojciech pl
dc.contributor.author Dudek, Dariusz [SAP20001398] pl
dc.date.accessioned 2020-01-17T08:43:53Z
dc.date.available 2020-01-17T08:43:53Z
dc.date.issued 2014 pl
dc.identifier.issn 1734-9338 pl
dc.identifier.uri https://ruj.uj.edu.pl/xmlui/handle/item/133835
dc.language eng pl
dc.rights Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Na tych samych warunkach 4.0 Międzynarodowa *
dc.rights.uri http://creativecommons.org/licenses/by-nc-sa/4.0/pl/legalcode *
dc.title Impact of intra-aortic balloon pump on long-term mortality of unselected patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock pl
dc.type JournalArticle pl
dc.description.physical 175-180 pl
dc.abstract.en Introduction: A large, randomised trial (IABP-SHOCK II) confirmed no benefit of intra-aortic balloon pump (IABP) on clinical outcomes of patients with ST-segment elevation myocardial infarction (STEMI) complicated by cardiogenic shock. However, the ‘sickest’ patients are often excluded from randomised clinical trials, so it is difficult to generalise expected outcomes from randomized clinical trials to the real life setting. Aim: We sought to evaluate the impact of IABP on 1-year mortality of unselected patients with STEMI presenting in cardiogenic shock. Material and methods: Data were gathered for 1,650 consecutive patients with STEMI transferred for primary angioplasty from hospital networks in 7 countries in Europe from November 2005 to January 2007 (the EUROTRANSFER registry population). Of them, 51 patients with cardiogenic shock on admission were identified and stratified based on the use of IABP. Outcome results were adjusted for age and sex, to control possible selection bias. Results: At the discretion of the operators, IABP was applied in 30 patients (58.8%, IABP group). The remaining 21 patients were treated without IABP (no-IABP group). The use of IABP was more frequent among males, younger patients, and patients with STEMI of the anterior wall. There was no difference in 30-day mortality in patients with and without IABP (no-IABP vs. IABP: 38.1% vs. 33.3%; adjusted OR 1.79 (95% CI 0.43–7.52); p = 0.43). Similarly, IABP had no impact on 1-year mortality (42.9% vs. 33.3%; adjusted OR 1.27 (95% CI 0.32–5.09); p = 0.74). One-year mortality was comparable among patients who survived hospitalisation (14.3% vs. 13%; p = 0.64). Conclusions: We observed no benefit of IABP on short – and long-term mortality of unselected patients with STEMI complicated by cardiogenic shock. pl
dc.subject.en intra-aortic balloon pump pl
dc.subject.en counterpulsation pl
dc.subject.en cardiogenic shock pl
dc.subject.en myocardial infarction pl
dc.subject.en angioplasty pl
dc.subject.en registries pl
dc.description.volume 10 pl
dc.description.number 3 (37) pl
dc.description.points 15 pl
dc.identifier.doi 10.5114/pwki.2014.45144 pl
dc.identifier.eissn 1897-4295 pl
dc.title.journal Postępy w Kardiologii Interwencyjnej pl
dc.language.container eng pl
dc.affiliation Wydział Lekarski : Instytut Kardiologii pl
dc.subtype Article pl
dc.rights.original CC-BY-NC-SA; otwarte czasopismo; ostateczna wersja wydawcy; w momencie opublikowania; 0 pl
dc.identifier.project ROD UJ / OP pl
dc.cm.id 67326
dc.cm.date 2020-01-07
.pointsMNiSW [2014 A]: 15


Files in this item

This item appears in the following Collection(s)

Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Na tych samych warunkach 4.0 Międzynarodowa Except where otherwise noted, this item's license is described as Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Na tych samych warunkach 4.0 Międzynarodowa